Cathepsin D--many functions of one aspartic protease.
暂无分享,去创建一个
[1] F. Jessen,et al. Cerebrospinal fluid levels of &bgr;-amyloid(42) in patients with Alzheimer's disease are related to the exon 2 polymorphism of the cathepsin D gene , 2002, Neuroreport.
[2] M. Schindl,et al. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density. , 2004, Gynecologic oncology.
[3] K. Yoneda,et al. Expression of transglutaminase 1 in human epidermis. , 1995, The Journal of investigative dermatology.
[4] G. Conner,et al. Proteolytic activation of human procathepsin D. , 1991, Advances in experimental medicine and biology.
[5] Isleifur Olafsson,et al. Inactivation of human cystatin C and kininogen by human cathepsin D , 1991, FEBS letters.
[6] R. S. Kiss,et al. Cathepsin D, a Lysosomal Protease, Regulates ABCA1-mediated Lipid Efflux* , 2006, Journal of Biological Chemistry.
[7] S. Scott,et al. Cathepsin D-mediated proteolysis of apolipoprotein E: Possible role in Alzheimer’s disease , 2006, Neuroscience.
[8] A. Samarel,et al. Susceptibilities of cardiac myofibrillar proteins to cathepsin D-catalyzed degradation. , 1983, American Journal of Physiology.
[9] Mahindra T. Makhija,et al. Correlation between inactive cathepsin D expression and retinal changes in mcd2/mcd2 transgenic mice. , 2005, Investigative ophthalmology & visual science.
[10] H. Rochefort,et al. Interactions of pro-cathepsin D and IGF-II on the mannose-6-phosphate / IGF-II receptor , 2005, Breast Cancer Research and Treatment.
[11] S. Yen,et al. Degradation of Tau by Lysosomal Enzyme Cathepsin D: Implication for Alzheimer Neurofibrillary Degeneration , 1997, Journal of neurochemistry.
[12] D. Scherman,et al. Inhibition of cathepsin D by tripeptides containing statine analogs. , 1999, Biochemical pharmacology.
[13] J. Kay,et al. Immunolocalization of cathepsin D in normal and neoplastic human tissues. , 1986, Journal of clinical pathology.
[14] H. Rochefort,et al. Specific mannose-6-phosphate receptor-independent sorting of pro-cathepsin D in breast cancer cells. , 1994, Experimental cell research.
[15] K. von Figura,et al. Alternative mechanisms for trafficking of lysosomal enzymes in mannose 6-phosphate receptor-deficient mice are cell type-specific. , 1999, Journal of cell science.
[16] H. Rochefort,et al. Cathepsin D in cancer metastasis: A protease and a ligand , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[17] H. C. Robinson,et al. Cathepsin D cleaves aggrecan at unique sites within the interglobular domain and chondroitin sulfate attachment regions that are also cleaved when cartilage is maintained at acid pH. , 2001, Matrix biology : journal of the International Society for Matrix Biology.
[18] B. Boehm,et al. A novel cell penetrating aspartic protease inhibitor blocks processing and presentation of tetanus toxoid more efficiently than pepstatin A. , 2007, Biochemical and biophysical research communications.
[19] D. Blacker,et al. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.
[20] V. Laurent-Matha,et al. A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells , 2001, Oncogene.
[21] L. Skoog,et al. The role of cathepsin D and PAI-1 in primary invasive breast cancer as prognosticators and predictors of treatment benefit with adjuvant tamoxifen. , 2000, European journal of cancer.
[22] J. W. Bird,et al. Degradation of myofibrillar proteins by cathepsins B and D. , 1977, The Biochemical journal.
[23] G. Sadik,et al. In vitro processing of amyloid precursor protein by cathepsin D. , 1999, The international journal of biochemistry & cell biology.
[24] J. Eaton,et al. Prevention of oxidant-induced cell death by lysosomotropic iron chelators. , 2003, Free radical biology & medicine.
[25] M. Baumann,et al. A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration , 2000, The EMBO journal.
[26] B. Dunn,et al. The two sides of enzyme-substrate specificity: lessons from the aspartic proteinases. , 2000, Biochimica et biophysica acta.
[27] P. Saftig,et al. Cathepsin D deficiency is associated with a human neurodegenerative disorder. , 2006, American journal of human genetics.
[28] S. Foundling,et al. Human breast milk contains procathepsin D--detection by specific antibodies. , 1993, Biochemistry and molecular biology international.
[29] R E Cachau,et al. Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[30] H. Rochefort,et al. Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein. , 1986, Endocrinology.
[31] V. Vetvicka,et al. Mitogenic function of human procathepsin D: the role of the propeptide. , 1994, The Biochemical journal.
[32] Y. Hannun,et al. Ceramide and apoptosis. , 1999, Trends in biochemical sciences.
[33] P. Eagles,et al. Studies using a fluorescent analogue of kinesin , 1991, Journal of Cell Science.
[34] E. Ring,et al. Secretion and localization of cathepsin D in synovial tissues removed from rheumatoid and traumatized joints. An immunohistochemical study. , 1976, Arthritis and rheumatism.
[35] Marcel Garcia,et al. Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells , 2002, Oncogene.
[36] P. Mecocci,et al. Interaction of CTSD and A2M polymorphisms in the risk for Alzheimer's disease , 2006, Journal of the Neurological Sciences.
[37] K. Roberg,et al. Lysosomal release of cathepsin D precedes relocation of cytochrome c and loss of mitochondrial transmembrane potential during apoptosis induced by oxidative stress. , 1999, Free radical biology & medicine.
[38] D. Leake. Does an acidic pH explain why low density lipoprotein is oxidised in atherosclerotic lesions? , 1997, Atherosclerosis.
[39] V. Vetvicka,et al. Secretion of cytokines in breast cancer cells: the molecular mechanism of procathepsin D proliferative effects. , 2007, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[40] R. Jacob,et al. The catalytically inactive precursor of cathepsin D induces apoptosis in human fibroblasts and HeLa cells , 2007, Journal of cellular biochemistry.
[41] V. Laurent-Matha,et al. Endocytosis of pro-cathepsin D into breast cancer cells is mostly independent of mannose-6-phosphate receptors. , 1998, Journal of cell science.
[42] N. Taniguchi,et al. Elevated activity and increased mannose-6-phosphate in the carbohydrate moiety of cathepsin D from human hepatoma. , 1988, Cancer research.
[43] S. Stevanović,et al. Cathepsin D Is Present in Human Eccrine Sweat and Involved in the Postsecretory Processing of the Antimicrobial Peptide DCD-1L* , 2006, Journal of Biological Chemistry.
[44] G. Coetzee,et al. Cathepsin-D-dependent initiation of the hydrolysis by lysosomal enzymes of apoprotein B from low-density lipoproteins. , 1980, European journal of biochemistry.
[45] J. Crissman,et al. Histologic assessment of cathepsin D in osteoarthritic cartilage. , 1986, Clinical and experimental rheumatology.
[46] A. Hasilik,et al. A replacement of the active-site aspartic acid residue 293 in mouse cathepsin D affects its intracellular stability, processing and transport in HEK-293 cells. , 2003, The Biochemical journal.
[47] M. Baumann,et al. Congenital ovine neuronal ceroid lipofuscinosis--a cathepsin D deficiency with increased levels of the inactive enzyme. , 2001, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[48] T. Holzman,et al. Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-beta by cathepsin D. , 1994, The Journal of biological chemistry.
[49] G. Miyamoto,et al. Proteases involved in the metabolic degradation of human interleukin-1beta by rat kidney lysosomes. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[50] K. von Figura,et al. Enhanced degradation of cathepsin D synthesized in the presence of the threonine analog beta-hydroxynorvaline. , 1984, Archives of biochemistry and biophysics.
[51] C. Peters,et al. Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. , 1995, EMBO Journal.
[52] E. Agostinelli,et al. Lysosomotropic compounds and spermine enzymatic oxidation products in cancer therapy (review). , 2007, International journal of oncology.
[53] H. Du,et al. Lysosomal Enzymes Are Released From Cultured Human Macrophages, Hydrolyze LDL In Vitro, and Are Present Extracellularly in Human Atherosclerotic Lesions , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[54] S. Kornfeld,et al. Lysosomal enzyme targeting. , 1990, Biochemical Society transactions.
[55] L. Juliano,et al. α1-Antichymotrypsin and Kallistatin Hydrolysis by Human Cathepsin D , 2000, Journal of protein chemistry.
[56] P. Saftig,et al. Altered Regulation of Phosphatidylinositol 3-kinase Signaling in Cathepsin D-Deficient Brain , 2007, Autophagy.
[57] A. Mizuno,et al. Pepstatin A, an aspartic proteinase inhibitor, suppresses RANKL-induced osteoclast differentiation. , 2006, Journal of biochemistry.
[58] V. Vetvicka,et al. Depletion of procathepsin D gene expression by RNA interference – A potential therapeutic target for breast cancer , 2007, Cancer biology & therapy.
[59] R. Baumgrass,et al. Identification of Peptide Fragments Generated by Digestion of Bovine and Human Osteocalcin with the Lysosomal Proteinases Cathepsin B, D, L, H, and S , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[60] F. Egberts,et al. Cathepsin D is involved in the regulation of transglutaminase 1 and epidermal differentiation , 2004, Journal of Cell Science.
[61] I. Silver,et al. Breast cancer cells have a high capacity to acidify extracellular milieu by a dual mechanism , 1997, Clinical & Experimental Metastasis.
[62] G. Berchem,et al. Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis , 2002, Oncogene.
[63] M. Fusek,et al. Two crystal structures for cathepsin D: the lysosomal targeting signal and active site. , 1993, The EMBO journal.
[64] N. Gebbia,et al. Effects of E-64 (cysteine-proteinase inhibitor) and pepstatin (aspartyl-proteinase inhibitor) on metastasis formation in mice with mammary and ovarian tumors. , 1994, In vivo.
[65] D. Neary,et al. Genetic associations between cathepsin D exon 2 C→T polymorphism and Alzheimer’s disease, and pathological correlations with genotype , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[66] A. Noël,et al. Catalytically inactive human cathepsin D triggers fibroblast invasive growth , 2005, The Journal of cell biology.
[67] I. Arany,et al. Response of keratinocytes from normal and psoriatic epidermis to interferon‐γ differs in the expression of zinc‐α2‐glycoprotein and cathepsin D , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[68] Mingde Zhao,et al. Sphingosine-induced apoptosis is dependent on lysosomal proteases. , 2001, The Biochemical journal.
[69] V. Vetvicka,et al. Anti‐human procathepsin D activation peptide antibodies inhibit breast cancer development , 1999, Breast Cancer Research and Treatment.
[70] A. Suzuki,et al. Cleavage of connectin by calpain and cathepsin D. , 1995, Bioscience, biotechnology, and biochemistry.
[71] T. Maudelonde,et al. CATHEPSIN D: AN INDEPENDENT PROGNOSTIC FACTOR FOR METASTASIS OF BREAST CANCER , 1989, The Lancet.
[72] J. Trojanowski,et al. Expression profile of transcripts in Alzheimer's disease tangle‐bearing CA1 neurons , 2000, Annals of neurology.
[73] L. Mazzucchelli,et al. Cathepsin D Specifically Cleaves the Chemokines Macrophage Inflammatory Protein-1α, Macrophage Inflammatory Protein-1β, and SLC That Are Expressed in Human Breast Cancer , 2003 .
[74] V. Vetvicka,et al. Ribozyme-targeting procathepsin D and its effect on invasion and growth of breast cancer cells: an implication in breast cancer therapy. , 2007, International journal of oncology.
[75] Carlo Follo,et al. Resveratrol induces cell death in colorectal cancer cells by a novel pathway involving lysosomal cathepsin D. , 2006, Carcinogenesis.
[76] J. Woessner,et al. Purification and Properties of Cathepsin D from Bovine Uterus , 1971 .
[77] Soo-Youl Kim,et al. Calpain inhibitors reduce the cornified cell envelope formation by inhibiting proteolytic processing of transglutaminase 1 , 1998, Experimental & Molecular Medicine.
[78] B. Dunn,et al. Aspartic Peptidase Inhibitors: Implications in Drug Development , 2003, Critical reviews in biochemistry and molecular biology.
[79] K. Öllinger,et al. Lysosomal membrane permeabilization during apoptosis ‐ involvement of Bax? , 2005, International journal of experimental pathology.
[80] R. Nixon,et al. Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[81] G. Berchem,et al. Overexpression of both catalytically active and -inactive cathepsin D by cancer cells enhances apoptosis-dependent chemo-sensitivity , 2006, Oncogene.
[82] V. Vetvicka,et al. The propeptide of cathepsin D increases proliferation, invasion and metastasis of breast cancer cells. , 2008, International journal of oncology.
[83] B. Posner,et al. Proteolysis of Glucagon within Hepatic Endosomes by Membrane-associated Cathepsins B and D (*) , 1995, The Journal of Biological Chemistry.
[84] A. Kimchi,et al. Cathepsin D protease mediates programmed cell death induced by interferon‐gamma, Fas/APO‐1 and TNF‐alpha. , 1996, The EMBO journal.
[85] K. Kato,et al. Identification of latent procathepsins B and L in microsomal lumen: characterization of enzymatic activation and proteolytic processing in vitro. , 1988, Archives of biochemistry and biophysics.
[86] J. Chirgwin,et al. Role of glycosylation in the expression of human procathepsin D. , 1995, Journal of cell science.
[87] B. Martin,et al. Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside. , 1997, Archives of biochemistry and biophysics.
[88] V. Vetvicka,et al. Possible role of procathepsin D in human cancer , 2008, Folia Microbiologica.
[89] Y. Takei,et al. Mitogenic activity toward human breast cancer cell line MCF-7 of two bFGFs purified from sera of breast cancer patients: co-operative role of cathepsin D , 1997, Breast Cancer Research and Treatment.
[90] Bruno Martoglio,et al. Aspartic proteases in drug discovery. , 2007, Current pharmaceutical design.
[91] P. Codogno,et al. Increase in Ceramide Level Alters the Lysosomal Targeting of Cathepsin D prior to Onset of Apoptosis in HT-29 Colon Cancer Cells , 2002, Biological chemistry.
[92] V. Vetvicka,et al. Analysis of the interaction of procathepsin D activation peptide with breast cancer cells , 1997, International journal of cancer.
[93] P. Roughley. The degradation of cartilage proteoglycans by tissue proteinases. Proteoglycan heterogeneity and the pathway of proteolytic degradation. , 1977, The Biochemical journal.
[94] Z. Gokaslan,et al. Expression of cathepsin D during the progression of human gliomas , 1996, Neuroscience Letters.
[95] Aldons J. Lusis,et al. Atherosclerosis : Vascular biology , 2000 .
[96] S. Singletary,et al. Prognostic Factors in Node-Negative Breast Cancer: A Review of Studies With Sample Size More Than 200 and Follow-Up More Than 5 Years , 2002, Annals of surgery.
[97] I. Touitou,et al. Missense polymorphism (C/T224) in the human cathepsin D pro-fragment determined by polymerase chain reaction--single strand conformational polymorphism analysis and possible consequences in cancer cells. , 1994, European journal of cancer.
[98] K. Kågedal,et al. Microinjection of cathepsin d induces caspase-dependent apoptosis in fibroblasts. , 2002, The American journal of pathology.
[99] J. Vonsattel,et al. Elevated Levels of the Endosomal‐Lysosomal Proteinase Cathepsin D in Cerebrospinal Fluid in Alzheimer Disease , 1995, Journal of neurochemistry.
[100] V. Vetvicka,et al. Role of procathepsin D activation peptide in prostate cancer growth , 2000, The Prostate.
[101] A. Lajtha,et al. Developmental changes in the breakdown of brain tubulin by cerebral cathepsin D , 2004, Neurochemical Research.
[102] A. Lajtha,et al. The breakdown of the individual neurofilament proteins by cathepsin D , 1987, Neurochemical Research.
[103] P. Isaacson,et al. Immunoproliferative small-intestinal disease. An immunohistochemical study. , 1989, The American journal of surgical pathology.
[104] G. Scambia,et al. Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: a meta-analysis. , 1997, British Journal of Cancer.
[105] W. Lowther,et al. Comparison of the active site specificity of the aspartic proteinases based on a systematic series of peptide substrates. , 1995, Advances in experimental medicine and biology.
[106] V. Vetvicka,et al. Procathepsin D in breast cancer: What do we know? Effects of ribozymes and other inhibitors , 2002, Cancer Gene Therapy.
[107] P. Scott,et al. Cathepsin D: Cleavage of soluble collagen and crosslinked peptides , 1978, FEBS letters.
[108] A. Hasilik,et al. Biosynthesis of lysosomal enzymes in fibroblasts. Synthesis as precursors of higher molecular weight. , 1980, The Journal of biological chemistry.
[109] G. Johnson,et al. A mutation in the cathepsin D gene (CTSD) in American Bulldogs with neuronal ceroid lipofuscinosis. , 2006, Molecular genetics and metabolism.
[110] S. Shangary,et al. Involvement of cathepsin D in chemotherapy-induced cytochrome c release, caspase activation, and cell death , 2005, Molecular Cancer Therapeutics.
[111] I. Christensen,et al. Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer. , 1989, Cancer research.
[112] Wei Li,et al. Induction of cell death by the lysosomotropic detergent MSDH , 2000, FEBS letters.
[113] F. Harper,et al. Cathepsin D Triggers Bax Activation, Resulting in Selective Apoptosis-inducing Factor (AIF) Relocation in T Lymphocytes Entering the Early Commitment Phase to Apoptosis* , 2003, Journal of Biological Chemistry.
[114] C. Hallas,et al. Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation , 2004, Cell Death and Differentiation.
[115] H. Nakanishi,et al. Cathepsin D Deficiency Induces Lysosomal Storage with Ceroid Lipofuscin in Mouse CNS Neurons , 2000, The Journal of Neuroscience.
[116] F. Jessen,et al. Contribution of Apolipoprotein E and Cathepsin D Genotypes to the Familial Aggregation of Alzheimer’s Disease , 2004, Dementia and Geriatric Cognitive Disorders.
[117] Wei Li,et al. Increased Expression and Translocation of Lysosomal Cathepsins Contribute to Macrophage Apoptosis in Atherogenesis , 2004, Annals of the New York Academy of Sciences.
[118] A. Samarel,et al. Effects of cysteine protease inhibitors on rabbit cathepsin D maturation. , 1989, The American journal of physiology.
[119] G. Giaccone,et al. Cell Death Independent of Caspases: A Review , 2005, Clinical Cancer Research.
[120] K. Kato,et al. Evidence that aspartic proteinase is involved in the proteolytic processing event of procathepsin L in lysosomes. , 1989, Archives of biochemistry and biophysics.
[121] H. Nakanishi,et al. Involvement of two different cell death pathways in retinal atrophy of cathepsin D-deficient mice , 2003, Molecular and Cellular Neuroscience.
[122] V. Laurent-Matha,et al. Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis. , 2006, Cancer letters.
[123] J. Skepper,et al. APOPTOSIS IN HUMAN MONOCYTE‐MACROPHAGES EXPOSED TO OXIDIZED LOW DENSITY LIPOPROTEIN , 1996, The Journal of pathology.
[124] P. Steinert,et al. Inactive zymogen and highly active proteolytically processed membrane-bound forms of the transglutaminase 1 enzyme in human epidermal keratinocytes. , 1996, Biochemical and biophysical research communications.
[125] G. Conner,et al. Isolation and characterization of a stable activation intermediate of the lysosomal aspartyl protease cathepsin D. , 1992, Biochemistry.
[126] V. Vetvicka,et al. Role of activation peptide of procathepsin D in proliferation and invasion of lung cancer cells. , 2006, Anticancer research.
[127] H. Rochefort,et al. MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. , 1991, Experimental cell research.
[128] N. Gebbia,et al. Cathepsin D expression levels in nongynecological solid tumors: Clinical and therapeutic implications , 2004, Clinical & Experimental Metastasis.
[129] V. Vetvicka,et al. Human procathepsin D: three-dimensional model and isolation. , 1995, Advances in experimental medicine and biology.
[130] G. Kroemer,et al. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine , 2003, Oncogene.
[131] F. Vizoso,et al. Clinical significance of cathepsin D concentration in tumor cytosol of primary breast cancer. , 2005, The International journal of biological markers.
[132] G. Conner,et al. Intermolecular association of lysosomal protein precursors during biosynthesis. , 1994, The Journal of biological chemistry.
[133] V. Vetvicka,et al. Effect of human procathepsin D on proliferation of human cell lines. , 1994, Cancer letters.
[134] A. Hasilik,et al. Stress-induced apoptosis is impaired in cells with a lysosomal targeting defect but is not affected in cells synthesizing a catalytically inactive cathepsin D , 2003, Cell Death and Differentiation.
[135] M. DiFiglia,et al. Lysosomal proteases are involved in generation of N-terminal huntingtin fragments , 2006, Neurobiology of Disease.
[136] P. Kelly,et al. A new mechanism for prolactin processing into 16K PRL by secreted cathepsin D. , 2006, Molecular endocrinology.
[137] G. Rubin,et al. Cathepsin D-deficient Drosophila recapitulate the key features of neuronal ceroid lipofuscinoses , 2005, Neurobiology of Disease.
[138] M. Benuck,et al. Metabolic instability of myelin proteins. Breakdown of basic protein induced by brain cathepsin D. , 1975, European journal of biochemistry.
[139] R. Bast,et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[140] T. Watanabe,et al. Participation of cathepsins B and D in apoptosis of PC12 cells following serum deprivation. , 1998, Biochemical and biophysical research communications.
[141] P. Pujol,et al. Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. , 1990, Oncogene.
[142] U. Brunk,et al. OxLDL-induced macrophage cytotoxicity is mediated by lysosomal rupture and modified by intralysosomal redox-active iron. , 1998, Free radical research.
[143] D. Kessel,et al. Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves bid cleavage , 2002, Cell Death and Differentiation.
[144] E. Ioachin. Immunohistochemical tumour markers in endometrial carcinoma. , 2005, European journal of gynaecological oncology.
[145] K. von Figura,et al. Lysosomal enzymes and their receptors. , 1986, Annual review of biochemistry.
[146] Y. Hannun,et al. Ceramide in the eukaryotic stress response. , 2000, Trends in cell biology.
[147] S. Mohammed,et al. Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques. , 2007, European journal of pharmacology.
[148] C. Gerçel-Taylor,et al. Modulation of proliferation and chemosensitivity by procathepsin D and its peptides in ovarian cancer. , 1999, Gynecologic oncology.
[149] V. Vetvicka,et al. Effect of procathepsin D and its activation peptide on prostate cancer cells. , 1998, Cancer letters.
[150] T. Matsumoto,et al. Purification of cathepsin D from rabbit skeletal muscle and its action towards myofibrils. , 1981, Biochimica et biophysica acta.
[151] J. Ioannidis,et al. Meta-analysis of the association of the cathepsin D Ala224Val gene polymorphism with the risk of Alzheimer's disease: a HuGE gene-disease association review. , 2004, American journal of epidemiology.
[152] H. Tazaki,et al. Hydrolysis of androgen receptor by cathepsin D: its biological significance in human prostate cancer. , 1998, British journal of urology.
[153] T. Maudelonde,et al. The Lancet: saturday 11 November 1989 , 1989 .
[154] J. Martial,et al. Cathepsin D processes human prolactin into multiple 16K-like N-terminal fragments: study of their antiangiogenic properties and physiological relevance. , 2004, Molecular endocrinology.
[155] Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[156] A. Zeiher,et al. Cathepsin D and H2O2 Stimulate Degradation of Thioredoxin-1 , 2005, Journal of Biological Chemistry.
[157] Carlo Follo,et al. Cathepsin D-Bax death pathway in oxidative stressed neuroblastoma cells. , 2007, Free radical biology & medicine.
[158] D. Selkoe. Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.
[159] G. Kroemer,et al. Lysosomal Membrane Permeabilization Induces Cell Death in a Mitochondrion-dependent Fashion , 2003, The Journal of experimental medicine.
[160] H. Rochefort,et al. Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells. , 1989, Cancer research.
[161] A. Olsson,et al. The toxicity to macrophages of oxidized low-density lipoprotein is mediated through lysosomal damage. , 1997, Atherosclerosis.
[162] N. Gebbia,et al. Pepstatins: Aspartic proteinase inhibitors having potential therapeutic applications , 1993, Medicinal research reviews.
[163] P. Stahl,et al. Cleavage of parathyroid hormone in macrophage endosomes illustrates a novel pathway for intracellular processing of proteins. , 1989, The Journal of biological chemistry.
[164] K. Blennow,et al. The Cathepsin D rs17571 polymorphism: effects on CSF tau concentrations in Alzheimer disease , 2006, Human mutation.
[165] V. Vetvicka,et al. Role of enzymatically inactive procathepsin D in lung cancer. , 2004, Anticancer research.
[166] H. Rochefort,et al. Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II. , 1990, Molecular endocrinology.
[167] W. Schneider-Brachert,et al. Cathepsin D targeted by acid sphingomyelinase‐derived ceramide , 1999, The EMBO journal.
[168] S. Yen,et al. Oxidative stress‐induced phosphorylation, degradation and aggregation of α‐synuclein are linked to upregulated CK2 and cathepsin D , 2007, The European journal of neuroscience.
[169] Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients , 1999, British Journal of Cancer.
[170] A. Lehesjoki,et al. Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. , 2006, Brain : a journal of neurology.
[171] K. von Figura,et al. Molecular forms of beta-hexosaminidase and cathepsin D in serum and urine of healthy subjects and patients with elevated activity of lysosomal enzymes. , 1983, The Biochemical journal.
[172] L. B. Larsen,et al. Identification of five molecular forms of cathepsin D in bovine milk. , 1995, Advances in experimental medicine and biology.
[173] P. Vandenabeele,et al. Non‐specific effects of methyl ketone peptide inhibitors of caspases , 1999, FEBS letters.
[174] R. Maciewicz,et al. Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D , 1996, International journal of cancer.
[175] V. Vetvicka,et al. Detection of procathepsin D in rat milk. , 2002, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.
[176] J. Eaton,et al. Lysosomal enzymes promote mitochondrial oxidant production, cytochrome c release and apoptosis. , 2003, European journal of biochemistry.
[177] T. Matsui,et al. Mechanism of regulation of human epidermal transglutaminase. , 1981, The Journal of investigative dermatology.
[178] C. Peters,et al. Amyloidogenic Processing of Human Amyloid Precursor Protein in Hippocampal Neurons Devoid of Cathepsin D* , 1996, The Journal of Biological Chemistry.
[179] J. Ježek,et al. Cathepsin D propeptide: mechanism and regulation of its interaction with the catalytic core. , 2006, Biochemistry.
[180] V. Vetvicka,et al. Procathepsin D secreted by HaCaT keratinocyte cells - A novel regulator of keratinocyte growth. , 2007, European journal of cell biology.
[181] H. Geuze,et al. Mannose 6-phosphate-independent targeting of cathepsin D to lysosomes in HepG2 cells. , 1991, The Journal of biological chemistry.
[182] P. Cohen,et al. Acid‐activated insulin‐like growth factor binding protein protease activity of Cathepsin D in normal and malignant prostatic epithelial cells and seminal plasma , 1997, Journal of cellular physiology.
[183] G. Gores,et al. Lysosomes in cell death , 2004, Oncogene.
[184] U. Felbor,et al. Generation and degradation of human endostatin proteins by various proteinases , 2000, FEBS letters.
[185] R. Sundler,et al. Cytosolic pH regulation in mouse macrophages. Proton extrusion by plasma-membrane-localized H(+)-ATPase. , 1992, The Biochemical journal.
[186] K. Öllinger,et al. Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. , 1998, The American journal of pathology.
[187] J. Olney,et al. Cathepsin D Deficiency Induces Persistent Neurodegeneration in the Absence of Bax-Dependent Apoptosis , 2007, The Journal of Neuroscience.
[188] Jinhe Li,et al. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal-lysosomal system , 1995, Neuron.
[189] S. Ishikawa,et al. Angiostatin Generation by Cathepsin D Secreted by Human Prostate Carcinoma Cells* , 2000, The Journal of Biological Chemistry.
[190] A. D. Dunn,et al. Thyroglobulin processing by thyroidal proteases. Major sites of cleavage by cathepsins B, D, and L. , 1991, The Journal of biological chemistry.
[191] P. Duchateau,et al. Conformational differences in human apolipoprotein B-100 among subspecies of low density lipoproteins (LDL). Association of altered proteolytic accessibility with decreased receptor binding of LDL subspecies from hypertriglyceridemic subjects. , 1994, The Journal of biological chemistry.
[192] C. Isidoro,et al. Cathepsin D released by lactating rat mammary epithelial cells is involved in prolactin cleavage under physiological conditions , 2004, Journal of Cell Science.
[193] P. Scott,et al. Cathepsin D: specificity of peptide-bond cleavage in type-I collagen and effects on type-III collagen and procollagen. , 2005, European journal of biochemistry.
[194] V. Vetvicka,et al. Effect of procathepsin D activation peptide on gene expression of breast cancer cells. , 2006, Cancer letters.
[195] V. Vetvicka,et al. Procathepsin D expression correlates with invasive and metastatic phenotype of MDA-MB-231 derived cell lines. , 2007, International journal of biological macromolecules.
[196] G. Blobel,et al. Biosynthesis of a lysosomal enzyme. Partial structure of two transient and functionally distinct NH2-terminal sequences in cathepsin D. , 1981, The Journal of biological chemistry.
[197] J. Pauls,et al. A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease , 2000, Annals of neurology.
[198] H. Grosch,et al. Purified recombinant human prosaposin forms oligomers that bind procathepsin D and affect its autoactivation. , 2004, The Biochemical journal.
[199] K. von Figura,et al. Processing of human cathepsin D in lysosomes in vitro. , 1985, The Journal of biological chemistry.
[200] A. Hasilik,et al. Biosynthesis of lysosomal enzymes in fibroblasts. Phosphorylation of mannose residues. , 1980, The Journal of biological chemistry.
[201] Katarina Kågedal,et al. The FASEB Journal express article 10.1096/fj.00-0708fje. Published online May 18, 2001. The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress , 2022 .
[202] J. Loscalzo,et al. The Macrophage and Fibrinolysis , 1996, Seminars in thrombosis and hemostasis.
[203] A. Paradiso,et al. Release of the aspartyl protease cathepsin D is associated with and facilitates human breast cancer cell invasion , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[204] D. Stover,et al. Mechanisms and kinetics of procathepsin D activation. , 1999, European journal of biochemistry.
[205] P. Pujol,et al. Estrogens and epithelial ovarian cancer. , 2004, Gynecologic oncology.
[206] C. Peters,et al. Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease). , 2005, The American journal of pathology.
[207] J. Loscalzo,et al. The fibrin(ogen)olytic properties of cathepsin D. , 1994, Biochemistry.
[208] B. Björkerud,et al. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. , 1996, The American journal of pathology.
[209] K. Hara,et al. Processing of cathepsins L, B and D in psoriatic epidermis , 1997, Archives of Dermatological Research.
[210] L. Gerweck,et al. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. , 1996, Cancer research.
[211] J. Shively,et al. Human placental fibronectin: demonstration of structural differences between the A and B chains in the extra domain-A region. , 1988, Archives of biochemistry and biophysics.
[212] C. Peters,et al. Potential role for Cathepsin D in p53-dependent tumor suppression and chemosensitivity , 1998, Oncogene.
[213] Fernández,et al. Cathepsin D in host stromal cells is associated with more highly vascular and aggressive invasive breast carcinoma , 1999, Histopathology.